Manufacturing the Future — Devens, Cell Therapy, and the $30B CAR-T Bet

Cell therapy is one of BMS's most strategic — and most operationally complex — businesses. The Devens, MA campus is the operational symbol of that bet. Candidates interviewing for manufacturing, supply chain, quality, regulatory, and even commercial roles in cell therapy need to understand the Devens story, the Breyanzi/Abecma franchise, and the unique challenges of CAR-T manufacturing.